We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Multidrug-Resistant Shigellosis Spreads Throughout the United States

By LabMedica International staff writers
Posted on 21 Apr 2015
International travelers are bringing a multidrug-resistant intestinal illness called shigellosis to the USA and spreading it to others who have not traveled. More...


Shigella sonnei, the causative bacteria of the disease, have become resistant to the antibiotic ciprofloxacin which is the first choice to treat shigellosis among adults in the USA. Shigellosis can spread very quickly in groups like children in childcare facilities, homeless people, and gay and bisexual men, as occurred in several outbreaks.

Scientists at the Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) identified an increase in Shigella sonnei infections with an uncommon genetic fingerprint in December 2014. Further testing at CDC's National Antimicrobial Resistance Monitoring System (NARMS) laboratory found that the bacteria were resistant to ciprofloxacin (Cipro). The CDC’s PulseNet network detected several large clusters: 45 cases in Massachusetts; 25 cases in California; and 18 cases in Pennsylvania. About half of these cases with patient information were associated with international travel, mostly to the Dominican Republic and India. The San Francisco Department of Public Health (CA, USA) reported another 95 cases, with 9 of them among those identified by PulseNet, with almost half occurring among the homeless or people living in single-room occupancy hotels.

Shigella causes an estimated 500,000 cases of diarrhea in the USA every year. It spreads easily and rapidly from person to person and through contaminated food and recreational water. It can cause watery or bloody diarrhea, abdominal pain, fever, and malaise. Although diarrhea caused by Shigella typically goes away without treatment, people with mild illnesses are often treated with antibiotics to stop the diarrhea faster.

Until recently, Cipro resistance has occurred in just 2% of Shigella infections tested in the USA, but was found in 90% of samples tested in the recent clusters. The CDC recommends that health care providers should test stool samples from patients with symptoms consistent with shigellosis, re-test stool if patients do not improve after taking antibiotics, and test bacteria for antibiotic resistance.

Anna Bowen, MD, MPH, a medical officer at the CDC and lead author of the study said, “Shigella is already resistant to the antibiotics ampicillin and trimethoprim/sulfamethoxazole. Globally, Shigella resistance to Cipro is increasing. The increase in drug-resistant Shigella makes it even more critical to prevent shigellosis from spreading. Washing your hands with soap and water is important for everyone. Also, international travelers can protect themselves by choosing hot foods and drinking only from sealed containers.”

Related Links:

Centers for Disease Control and Prevention 
San Francisco Department of Public Health 



Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
PlGF Test
Quidel Triage PlGF Test
New
Automatic Hematology Analyzer
LABAS F9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.